1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
662EB8ADF8029BFE965257CA2001F9B57
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/payer-market-research-assessing-tools-and-techonolgies-gain-insight-in-decision-making
18
19
20172.70.163.70
21
22
23116639.0ncwlf7ax.asia
24/bestp/domrep.nsf
25BMR




» Products & Services » »

Increasing Market Access through Innovative Payer Market Research: Assessing New Tools & Technologies to Gain Insight into Payer Decision Making

ID: PSM-304


Features:

20+ Info Graphics

20+ Data Graphics

200+ Metrics

20+ Narratives


Pages: 95


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

Buy this research as part of a

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
The health care marketplace is rapidly and sometimes chaotically evolving. The overall influence of payers is rising and the types of payers influencing health care access is diversifying. Any company hoping to compete and win in this “brave new world” must understand the “payer ecosystem” and learn to navigate through it.


Best Practices, LLC conducted this research to probe how health care companies structure internal research groups conducting payer research, and it assesses what market research approaches are most effective and innovative for understanding diverse payer needs, preferences and decision-making. This study also examines what research techniques work best during all product lifecycle stages to ensure access for therapies through national, regional and government payers and through Accountable Care Organizations and Integrated Health Delivery Networks.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Insurance; Manufacturing; Consumer Products; Biopharmaceutical; Chemical; Market Research; Education; Consulting; Communications


Companies Profiled:
Abbott; Hobart Innovations; Abbott Diabetes Care; Abbott Nutrition; Astellas; AstraZeneca; AstraZeneca Neuroscience; Amgen; Baxter International; CDMI; Boehringer Ingelheim; Biogen Idec; Bayer; Biomet; Baxter BioScience; Drager; GE Healthcare; Gilead Sciences; Genentech; EMD Serono; GlaxoSmithKline ; GSW; Galderma; Ipsen; Joerns Healthcare; Endo Pharmaceuticals; Indi; Novo Nordisk; Mako Surgical Corp.; Medtronic CRDM; Kadmon Pharmaceuticals; Xcenda; Medtronic Neuromodulation; Phillips; NPS; Masimo; Walgreens; Health Interactions

Study Snapshot

The study participants engaged 38 executives and managers working in diverse payer-focused functions through a benchmarking survey instrument and field interviews. Research analysts conducted executive interviews with five leaders to collect qualitative data and insights.

The key topics include:

  • Prioritizing Players in the Complex Payer Landscape: Which Payers Most Impact Your Business
  • Optimizing Your Payer Research Structure to Capture Managed Markets Insights
  • Market Research Resources for Conducting Impactful Payer Research
  • Engaging Payers & Harvesting Insights across the Product Lifecycle
  • Payer Landscape Research Activities & Timing
  • Payer Contracting Research Activities & Timing
  • Formulary Research Activities & Timing to Gauge Payer Perspectives
  • Effective Tools & Technologies to Capture Payer Insights
  • Future Trends & Lessons Learned in Conducting Payer Research for Greater Market Access

Sample Key Findings

Mapping the Payer Landscape
  • Payer Landscape Research Is Well Used and Highly Valued:
      • Up to 86% use payer landscape research tactics to understand payer decision making
      • Value-proposition testing with payers is the most heavily used and most effective tactic
      • Mock P&T committees are used to explore parameters that could change payer thinking
  • Regional Payers Are Increasingly Important Focus for Market Research:
      • Although many pay more attention to national payers, they are beginning to include regionalized approach
      • Three-quarters of respondents examine how regional payers evaluate products in a therapeutic area
      • Regional focus deepens ACO knowledge; opens opportunities with regional payers
      • Almost 80% conduct value proposition testing for regional payers.
Table of Contents

Research Overview
  • Universe of Learning
  • Key Findings & Insights for Managing the Payer Ecosystem
  • Mapping the Rapidly Evolving Payer Ecosystem
  • Effective Tools & Technologies to Understand Payer Decision-making
  • Key Trends in Managed Markets Contracting Research
  • Key Trends in Payer Formulary & Tracking Research
  • Understanding What Drives National & Regional Payer Decision-making
  • Understanding What Drives Government Payer Decision-making
  • ACOs & IDNs Are Rising in Importance
  • Cross-Functional Collaboration & Communication Are Critical
  • Optimizing Payer Research Structures, Roles & Resources
  • Preparing to Compete in an Outcomes-oriented World
  • Appendix